| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30055939 | HIV | ENSG00000186951.17 | protein_coding | PPARA | No | No | 5465 | Q07869 |
| TVIS30055940 | HIV | ENSG00000186951.17 | protein_coding | PPARA | No | No | 5465 | Q07869 |
| TVIS30055941 | HIV | ENSG00000186951.17 | protein_coding | PPARA | No | No | 5465 | Q07869 |
| TVIS20040704 | HPV | ENSG00000186951.17 | protein_coding | PPARA | No | No | 5465 | Q07869 |
| TVIS44043072 | HTLV-1 | ENSG00000186951.17 | protein_coding | PPARA | No | No | 5465 | Q07869 |
| TVIS44048213 | HTLV-1 | ENSG00000186951.17 | protein_coding | PPARA | No | No | 5465 | Q07869 |
| TVIS44048233 | HTLV-1 | ENSG00000186951.17 | protein_coding | PPARA | No | No | 5465 | Q07869 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | PPARA |
|---|---|
| DrugBank ID | DB03796 |
| Drug Name | Palmitic Acid |
| Target ID | BE0000071 |
| UniProt ID | Q07869 |
| Regulation Type | |
| PubMed IDs | 10403814 |
| Citations | Murakami K, Ide T, Suzuki M, Mochizuki T, Kadowaki T: Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha. Biochem Biophys Res Commun. 1999 Jul 14;260(3):609-13. |
| Groups | Approved |
| Direct Classification | Long-chain fatty acids |
| SMILES | CCCCCCCCCCCCCCCC(O)=O |
| Pathways | Cerivastatin Action Pathway; Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCAD); Ethylmalonic Encephalopathy; Familial Hypercholanemia (FHCA); Desmosterolosis; Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD Deficiency); Congenital Bile Acid Synthesis Defect Type III; Glycerolipid Metabolism; Ibandronate Action Pathway; Cerebrotendinous Xanthomatosis (CTX); Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2); Smith-Lemli-Opitz Syndrome (SLOS); Carnitine Palmitoyl Transferase Deficiency II; Hyper-IgD Syndrome; Zellweger Syndrome; Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD); Steroid Biosynthesis; Hypercholesterolemia; Risedronate Action Pathway; Mevalonic Aciduria; Glutaric Aciduria Type I; Alendronate Action Pathway; CHILD Syndrome; D-Glyceric Acidura; Lovastatin Action Pathway; Wolman Disease; Bile Acid Biosynthesis; Long Chain Acyl-CoA Dehydrogenase Deficiency (LCAD); Glycerol Kinase Deficiency; Atorvastatin Action Pathway |
| PharmGKB | |
| ChEMBL | CHEMBL82293 |
